The accumulation of β‑amyloid peptides (Aβ) in the brain is a hallmark of Alzheimer's
disease (AD). Studies have indicated that ginsenoside Rg1, a primary component of …

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the
accumulation of β-amyloid plaques and hyperphosphorylated tau proteins in the brain. Cell …

The level of β-site APP-cleaving enzyme 1 (BACE1) has been documented to increase in
the brains of patients with Alzheimer's disease, which has resulted in elevation of β-amyloid …

Background and Purpose The present study was designed to examine the effects of
ginsenoside Rg1 on expression of peroxisome proliferator-activated receptor γ (PPARγ) and …

Ginsenoside Rg1 inhibits oxidation, aging and cell apoptosis, and improves cognitive
function. In this study, we pretreated rat brain tissue sections with ginsenoside Rg1, and …

It is well established that the presence of soluble amyloid-β protein (Aβ) correlates with the
severity of dementia in Alzheimer's disease (AD). Several lines of evidence indicate that …

It has been demonstrated that peroxisome proliferator-activated receptor γ (PPARγ) can
regulate the transcription of its target gene, insulin-degrading enzyme (IDE), and thus …

Alzheimer's disease (AD) is one of the most debilitating neurodegenerative diseases in an
aging population. Excessive accumulation of β-amyloid (Aβ) has been proposed as a pivotal …

There has been no extensive characterization of the effects of Ginsenoside Rg1, a
pharmacological active component purified from the nature product ginseng, in an …

Abstract Ethnopharmacological relevance Ginsenoside Rg2 is an important ingredient of
Panax ginseng which often appears in ancient prescriptions for forgetfulness. Ginsenoside …